Global Retinal Disorders Landscape Report 2017 - Focus on Avastin, Eylea, Lucentis & Ozurdex

Wednesday, February 7, 2018 1:30 AM UTC

Dublin, Feb. 06, 2018 -- The "Retinal Disorders" report has been added to ResearchAndMarkets.com's offering.

A range of disorders, some of which share similar underlying pathologies, can affect the retina and lead to progressively worsening vision and eventual blindness. The retina is the layer of light-sensitive tissue at the back of the eye that converts light into impulses to the brain via the optic nerve. A common feature of certain retinal disorders is abnormal growth of blood vessels in the macula, which can be effectively treated by drugs targeting vascular endothelial growth factor. These discrete indications are wet age-related macular degeneration, diabetic retinopathy with and without diabetic macular edema, and macular edema from retinal vein occlusion.

Key Topics Covered:

1 TREATMENT: RETINAL DISORDERS

Executive Summary
Primary Research Methodology
Disease Definition and Diagnosis
Patient Segmentation
Current Treatment Options
Prescribing Trends
Unmet Needs in Retinal Disorders

2 MARKETED DRUGS: RETINAL DISORDERS

Executive Summary
Product Overview
Product profile: Avastin
Product profile: Eylea
Product profile: Lucentis
Product profile: Ozurdex

3 PIPELINE: RETINAL DISORDERS

Executive Summary
Clinical Pipeline Overview
Product profile (late stage): Zuprata
Product profile (late stage): abicipar pegol
Product profile (late stage): brolucizumab
Product profile (late stage): squalamine

For more information about this report visit https://www.researchandmarkets.com/research/b2mtk7/global_retinal?w=12



CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Optical

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Global Retinal Disorders Landscape Report 2017 - Focus on Avastin, Eylea, Lucentis & Ozurdex

Editor's Picks

Welcome to EconoTimes